Medidata Solutions ROE 2009-2018 | MDSO

Current and historical return on equity (ROE) values for Medidata Solutions (MDSO) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.007B $0.546B
Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer), investigator benchmarking and budgeting (Medidata Grants Manager), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes some top global pharmaceutical companies.
Stock Name Country Market Cap PE Ratio
Cerner (CERN) United States $20.397B 28.33
Athenahealth (ATHN) United States $6.524B 62.57
Foundation Medicine (FMI) United States $5.063B 0.00
Allscripts Healthcare Solutions (MDRX) United States $2.217B 25.96
Omnicell (OMCL) United States $2.090B 101.42
HMS Holdings Corp (HMSY) United States $2.015B 44.02
IRHYTHM TECH (IRTC) United States $2.010B 0.00
Tabula Rasa Healthcare (TRHC) United States $1.333B 0.00
Quality Systems (QSII) United States $1.270B 35.98
Inspire Medical Systems (INSP) $0.893B 0.00
Senseonics Holdings (SENS) United States $0.566B 0.00
Invitae (NVTA) United States $0.557B 0.00
Computer Programs And Systems (CPSI) United States $0.483B 21.04
NantHealth (NH) United States $0.343B 0.00
Motus GI Holdings (MOTS) United States $0.128B 0.00
FULGENT GENETIC (FLGT) United States $0.081B 0.00
Digirad (DRAD) United States $0.033B 0.00
Streamline Health Solutions (STRM) United States $0.029B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Transgenomic (PRPO) United States $0.007B 0.00